title: Treatment of AML in biological subgroups.
authors.affiliation: Department of Hematology and Oncology, University Medical Center, Muenster, Germany. buechnr@uni-muenster.de
authors.forename: Thomas
authors.initials: T
authors.lastname: Buechner
authors.forename: Wolfgang E
authors.initials: WE
authors.lastname: Berdel
authors.forename: Claudia
authors.initials: C
authors.lastname: Schoch
authors.forename: Torsten
authors.initials: T
authors.lastname: Haferlach
authors.forename: Hubert L
authors.initials: HL
authors.lastname: Serve
authors.forename: Susanne
authors.initials: S
authors.lastname: Schnittger
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Kern
authors.forename: Joelle
authors.initials: J
authors.lastname: Tchinda
authors.forename: Albrecht
authors.initials: A
authors.lastname: Reichle
authors.forename: Peter
authors.initials: P
authors.lastname: Staib
authors.forename: Wolf-Dieter
authors.initials: WD
authors.lastname: Ludwig
authors.forename: Carlo
authors.initials: C
authors.lastname: Aul
authors.forename: Maria-Cristina
authors.initials: MC
authors.lastname: Sauerland
authors.forename: Achim
authors.initials: A
authors.lastname: Heinecke
authors.forename: Bernhard
authors.initials: B
authors.lastname: Woermann
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Hiddemann
mesh_terms: D000208:Acute Disease; D000367:Age Factors; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D011379:Prognosis; D012307:Risk Factors